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Abstract The metabolite-modulated association of a fraction of
hexokinase to mitochondria in brain is well documented,
however, the involvement of other non-mitochondrial components
in the binding of the hexokinase is controversial. Now we present
evidence that the hexokinase binds both tubulin and microtubules
in brain in vitro systems. The interaction of tubulin with purified
bovine brain hexokinase was characterized by displacement
enzyme-linked immunosorbent assay using specific anti-brain
hexokinase serum (IC50 = 4.0 þ 1.4 WM). This value virtually was
not affected by specific ligands such as ATP or glucose 6-
phosphate. Microtubule-bound hexokinase obtained in reconsti-
tuted systems using microtubule and purified hexokinase or brain
extract was visualized by transmission and immunoelectron
microscopy on the surface of tubules. The association of purified
bovine brain hexokinase with either tubulin or microtubules
caused about 30% increase in the activity of the enzyme. This
activation was also observed in brain, but not in muscle cell-free
extract. The possible physiological relevance of the multiple
heteroassociation of brain hexokinase is discussed. ß 2001
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Architecture of cytoplasm in eukaryotic cells is highly or-
ganized; it contains complex networks of the cytoskeletal ¢l-
ament systems, which are decorated by cytosolic proteins in-
cluding glycolytic enzymes. Heterologous associations of
glycolytic enzymes have been demonstrated in several cell
types (for reviews see [1,2]). Indeed, subcellular particles are
associated with activities of several glycolytic enzymes from
brain homogenate or synaptosomes (reviewed by Knull [3,4]).
Glycolytic enzymes together with several other metabolic en-
zymes have been identi¢ed in axonal transport in vivo as a
discrete macromolecular cellular entity [5,6].
Brain hexokinase (hexokinase-I, HK), a key enzyme of the
glucose metabolism, binds to the outer mitochondrial mem-
brane [7,8] or is in the cytosolic fraction (soluble form) de-
pending on the energy needs of the brain [9]. This interaction
is sensitive to the concentrations of several ions and metabo-
lites, speci¢cally to the level of glucose 6-phosphate [10]. In
addition, the distribution of free and bound forms of HK is
species-dependent [11]. However, there are data in the litera-
ture, which suggest that in brain, HK has a greater propensity
to localize at non-mitochondrial receptor sites [12,13]. In the
neurons of central nervous system the majority of HK moves
toward the presynaptic terminals at rates several times slower
than that exhibited by the mitochondria [14], and is localized
in slow component b (SCb) [15]. Data on other cell types also
suggest that HK does not bind exclusively to the mitochon-
dria. There has been prior evidence that HK can bind to
microsomes, plasma membrane or cytoskeletal elements in
close proximity to mitochondria [12,16^18].
In this paper the interaction of brain HK with tubulin or
microtubule (MT) is detected in reconstituted system using
binding and kinetic assays and is visualized by electron mi-
croscopy. The experiments have been carried out with puri¢ed
brain HK and cell-free extracts prepared from brain and
muscle tissues. The a⁄nity of the binding of tubulin to HK
was determined from enzyme-linked immunosorbent assay
(ELISA) displacement experiments.
2. Materials and methods
2.1. Materials
Rabbit anti-HK serum and preserum were kindly provided by Prof.
J.E. Wilson (Michigan State University). ATP, bovine serum albumin
(BSA), NADP, NADH were purchased from Sigma Chemical Co.
(Sigma Chemical Co., St. Louis, MO, USA). Tubulin, MT and the
cell-free brain and muscle extracts were prepared as described previ-
ously [19,20].
2.2. Partial puri¢cation of bovine brain HK
The puri¢cation procedure described for rat brain HK [21,22] was
adapted with slight modi¢cation. Brie£y, the homogenized bovine
brain was centrifuged at 30 000Ug at 4‡C for 30 min. Triton X-100
was added to the pellet fraction to release a signi¢cant fraction of
bound HK. Triton X-100 was removed from the solubilized HK by an
anion exchange chromatography on DE 52 cellulose and the bound
HK was eluted by 100^150 mM KCl. Then the HK was further
puri¢ed by a⁄nity chromatography using A⁄-Gel Blue column.
The speci¢c activity of the bovine brain HK preparation with
s 80% purity was 20 þ 2 U/mg.
2.3. HK assay
Activity of HK was assayed according to Grossbard and Schimke
[23]. The experiments were carried out in HEPES bu¡er (50 mM, pH
7.4, containing 100 mM KCl, 10 mM MgCl2, 10 mM NaH2PO4), 0.4
U/ml glucose 6-phosphate dehydrogenase, 1 mM NADP and 2 mM
MgATP, starting the reactions with the addition of 1 mM glucose.
The NADPH-production was monitored by a Cary 50 spectropho-
tometer at 25‡C.
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2.4. ELISA experiments
Standard ELISA protocols [24] for indirect assays were used with
some modi¢cations as follows.
For standard assay, coating of plate with HK (5 Wg/ml) was done
for 18 h at 6‡C. Incubation time was 90 min for rabbit anti-HK
serum, than 90 min for the anti-rabbit antibody^horseradish peroxi-
dase conjugate at di¡erent dilutions depending on the batches. o-Phe-
nylenediamine substrate was used at 3.7 mM concentration and at 492
nm after 5 min hydrolysis time, the reaction was stopped by addition
of 1 M H2SO4 and the absorbances were read at 492 nm on Anthos II
microplate reader. Immunoreaction was not detected when preim-
mune serum was used instead of anti-HK serum.
For displacement experiments, tubulin at various concentrations
was added to the coated HK (5 Wg/ml), and preincubated with the
anti-HK serum for 15 min. Subsequent steps were the same as those
described for the standard assay. We used at least four parallel wells
in a plate for each concentration and each experiment was repeated at
least three times.
2.5. Binding to MT
Taxol-stabilized MAP (MT-associated protein)-free MT was pre-
pared as described previously [19]. MT, puri¢ed HK or brain extract
were centrifuged (40 000Ug, 25 min, 25‡C) separately, than MTs from
the pellet fraction was preincubated with either puri¢ed HK or with
brain extract from the supernatants in 100 mM MES bu¡er, pH 7.1,
containing 5 mM MgCl2 at 37‡C for 15 min. Final concentrations of
MT, brain HK, and brain extract were 2, 0.18 and 10 mg/ml, respec-
tively. The MTs with the bound proteins were collected by centrifu-
gation (40 000Ug, 25 min, 37‡C) and electron microscopic studies
were carried out. Under these experimental conditions about 5 Wg
HK cosedimented with 2 mg MTs.
2.6. Electron and immunoelectron microscopy
For routine electron microscopy, MT-containing samples were ¢xed
in a mixture of 2% glutaraldehyde, 0.2% tannic acid and 0.1 M so-
dium cacodylate, pH 7.4, for 1 h, post¢xed in 0.5% OsO4 and em-
bedded in Durcupan (Fluka, Switzerland). Thin sections were con-
trasted with uranyl acetate and lead citrate and examined in a
JEOL CX 100 electron microscope.
For immunogold electron microscopy MT preparations were ¢xed
in 2% paraformaldehyde/0.5% glutaraldehyde in 0.1 M cacodylate
bu¡er (pH 7.4) containing 1% sucrose and 2 mM CaCl2 for 1 h,
then washed, stained en bloc with 1% uranyl acetate, dehydrated
and embedded in Durcupan. Sections collected on nickel grids, were
etched in 5% H2O2 then washed in double distilled water, blocked
with 0.5% non-fat dry milk powder and 1% BSA followed by incu-
bation on a drop of rabbit anti-brain HK-IgG serum at a dilution of
1:100 in a humid chamber at 4‡C overnight. After rinsing in 1% BSA
in phosphate bu¡ered saline the grids were transferred on to a drop of
biotinylated goat antibody against rabbit IgG (Vector Labs., Peter-
borough, UK; 1:200 dilution). After washing in 1% BSA in phos-
phate bu¡ered saline the grids were £oated on a drop of anti-biotin
gold (10 nm, Bio-Cell, Cardi¡, UK; 1:100 dilution) in a humid cham-
ber at 4‡C for 5 h. Immunostained sections were examined in the
electron microscope without counterstaining. Control sections were
processed as described above, however, the ¢rst, HK-speci¢c antibody
was omitted.
3. Results
3.1. Activation of brain HK by tubulin or MT
In many cell types the major control step of glycolysis is the
HK-catalyzed reaction. Recently, we have demonstrated that
the £ux of the upper part of glycolysis, from glucose to triose
phosphates, controlled by HK, is increased by tubulin or MT
[25,26] in the cell-free extracts of brain, but not of muscle
tissue. Now we investigated the direct involvement of HK in
the process.
Fig. 1 shows the e¡ects of tubulin, MT and BSA, as an
inert protein on the activity of HK in puri¢ed form and in
brain and muscle extracts. In the case of puri¢ed enzyme
approximately 30% activation was detected when 1 mg/ml
tubulin was added to the activity assay without preincubation
as compared to the control (no tubulin added). This activa-
tion was not seen by addition of 1 mg/ml BSA. The extent of
activation was not further increased elevating the tubulin con-
centration, but it was maintained at tubulin concentration as
low as 0.3 mg/ml (data not shown). As also shown in Fig. 1
MT, the assembled form of tubulin, exerts its activating
Fig. 1. E¡ects of tubulin, MT and BSA on the activity of HK in
brain and muscle extract, and on puri¢ed brain HK. Tubulin (T)
(striped bar) or MT (dotted bar) or BSA concentrations were 1 mg/
ml; the concentrations of brain and muscle extracts, and brain HK
were 0.8 mg/ml, 0.7 mg/ml, and 0.25 Wg/ml respectively.
Fig. 2. A: Indirect ELISA for measuring immunocomplex forma-
tion. Absorbance was measured at 492 nm as a function of anti-HK
serum dilution. B: Displacement curve of tubulin using 1000 fold
diluted serum concentration.
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e¡ect on brain HK as well, similarly to that obtained with
tubulin.
Addition of tubulin or MTs to brain extract in which many
proteins are present and known to interact with MTs resulted
in an about 20% activation of HK (cf. Fig. 1). This activation
was not, however, obtained when muscle extract under similar
conditions was used instead of brain extract. Since the muscle
contains another isoform of HK (HK-II), the negative data
obtained with muscle extract or with BSA (cf. Fig. 1) indicate
the relevance of the speci¢c HK^tubulin interaction in the
brain system.
3.2. Characterization of the binding of brain HK to tubulin
Displacement ELISA experiments were carried out to detect
the binding of tubulin to the coated HK. Fig. 2A shows the
saturation (dilution) curve measured with anti-HK serum us-
ing 5 Wg/ml HK to cover the microtiter wells. The immobilized
tubulin captures anti-HK antibodies from the serum, which
was visualized after addition of appropriate amount of the
second immunoglobulin conjugate under conditions, which
ensure direct proportionality during the peroxidase reaction
(A492) [27]. The immunocomplex formed is characterized by
IC50 = 3500 þ 700 fold dilution.
On the basis of Fig. 2A, 1000 fold dilution of the anti-HK
serum was used to detect the e¡ect of tubulin on the immu-
nocomplex formation with high sensitivity. The binding of
antibodies to HK is inhibited by increasing the tubulin con-
centration as shown in Fig. 2B, and complete displacement
can be reached at near 100 WM concentration. The IC50 value
determined was 4.0 þ 1.4 WM. This value is in the same order
of magnitude as we observed in the case of other glycolytic
enzymes [28,29].
The e¡ects of glucose 6-phosphate and MgATP on the
HK^tubulin interaction were also tested by ELISA, under
similar conditions as described for Fig. 2B. We found that
the presence of these metabolites at 1 mM concentrations
did not cause signi¢cant perturbation of HK^tubulin interac-
tion (data not shown). The ¢nding that the speci¢c metabo-
lites of HK did not induce the dissociation of the HK from
tubulin suggests that other interactive forces are involved in
this heteroassociation than those observed in the case of HK
binding to mitochondria [10].
3.3. Visualization of HK on MT
To study the morphologic background lying behind the
binding of HK to MT and the enzyme activation, HK-bound
MT samples were prepared and visualized by electron micro-
scope. The MTs were pelleted in the presence of puri¢ed HK
or brain extract with appropriate sedimentation velocity to
separate the free and the bound proteins [28]. The pellets
prepared without addition of HK or brain extract contain
more or less parallel-aligned smooth-surfaced MTs of about
25 nm of diameter as we demonstrated previously [30]. How-
ever, a very ¢ne, sparse decoration is seen on several MTs
made with addition of HK (Fig. 3a). When MTs cosedi-
mented with brain cell-free extract were visualized heavy de-
posits of electron dense aggregates appeared on the MTs (Fig.
3b) due to the binding of several cytosolic proteins as we have
reported previously [26,31]. To see whether the decorating
material contains HK, immunogold labelling was applied to
samples of MTs incubated either in the presence of puri¢ed
brain HK (Fig. 3c) or brain extract (Fig. 3d). As shown in
these ¢gures, immunogold conjugates are clearly present on
the MTs. No immunostaining is seen on MTs made without
addition of HK or brain extract, and non-speci¢c labelling is
negligible on control sections incubated in the absence of ¢rst
Fig. 3. Electron microscopic images of MTs incubated in the presence of puri¢ed brain HK (a, c) and brain cytosolic extract (b, d) and pro-
cessed for routine electron microscopy (a, b) or immunolabelled by anti-brain HK antibody followed by biotin^gold-conjugated anti-biotin
staining (c, d). Note the decoration of MTs (arrows) in (a) and (b) and the presence of 10 nm gold particles (arrowheads) on the MTs in (c)
and (d). Bars: 100 nm in (a) and (b) and 200 nm in (c) and (d).
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antibody (data not shown). Therefore, the electron microscop-
ic images provide evidence that MTs and HK recognize each
other, even in high excess of other cytosolic proteins.
4. Discussion
Our present observations that the brain isoform of HK can
bind to tubulin and MT and the binding causes the activation
of HK in vitro in brain systems suggest that the microtubular
network could be a potential target for HK binding. The
negative results (no interaction) of control experiments carried
out with muscle extract, which contains another isoform of
HK or with BSA suggest the speci¢c character of the hetero-
association of brain HK. This heteroassociation could be im-
portant from structural and physiological point of views, since
in neuronal cells the concentration of MT, the major compo-
nent of the axons, is very high, and HK plays a key role in the
control of the glycolysis ; especially in brain where glucose is
the major energy source. It is well documented that a fraction
of HK, reversibly associated with the mitochondrial mem-
brane, is releasable speci¢cally by glucose 6-phosphate, which
results in the conversion of the active HK species into a less
active form [32]. When associated with mitochondria, the af-
¢nity of the enzyme for ATP is elevated and sensitivity to
inhibition by glucose 6-phosphate is lowered [10]. There are
data, on the other hand, which show the signi¢cant sequestra-
tion of HK by non-mitochondrial cell components including
membranes of endoplasmic reticulum/microsomes [18], actin
¢laments [18] and other cytoskeletal components [14]. Our
present data support this idea and provide evidence for the
binding of brain HK to both tubulin and MTs. The functional
consequences of these associations are probably far-reaching.
The kinase is activated due to this heteroassociation as in the
case of mitochondrial binding, however, this interaction is
glucose 6-phosphate and MgATP-independent. The fact,
that HK is allosterically regulated by a couple of speci¢c
ions and metabolites, and a fraction of the enzyme occurs in
particle-bound forms which exhibit di¡erent catalytic proper-
ties, indicates that the energy state of brain cell is ¢nely con-
trolled by multiple equilibrium in which the microtubular sys-
tem may be involved. Increased £uxes through HK/glucose 6-
phosphate dehydrogenase coupled enzymatic reactions in the
presence of brain tubulin and MTs were reported by Cortassa
et al. [33]. Several reports suggest that the MTs may interact
with mitochondria via binding MT-associated proteins
(MAP2) to the pore-containing domain of the outer mito-
chondrial membrane [34,35]. These observations strengthen
the view that ¢ne interplay may exist between these two cell
components in the regulation of location and activity of HK.
The association of HK to MTs may regulate the susceptibility
of the enzyme to degradation. This suggestion is based on the
observation of Magnani et al. [13] who showed that the solu-
ble but not mitochondria-bound HK is a good substrate of
the ubiquitin-dependent proteolytic system.
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